Sign in
4

Changes in Ownership

Whitehawk Therapeutics, Inc. Filed Acc 0001415889-25-006318

CHIEF FINANCIAL OFFICER sold 2,806 shares at $2.35 ($6,594)

  • CHIEF FINANCIAL OFFICER acquired 6,750 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2025-03-01 Option exercise +6,750 26,750 D
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2025-03-03 Sale −2,806 $2.35 $6,594 23,944 D
Derivatives
Giacobello Scott M. CHIEF FINANCIAL OFFICER 2025-03-01 Option exercise · Restricted Stock Units −6,750 20,250 D
Open-market sales · 2,806 sh · avg $2.35 · $6,594
Loading xslF345X05/form4-03042025_010336.xml…